Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, indicating a site build/version bump without any change to the clinical study content shown.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to page content or user-facing features.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.4.3 is now shown on the page, replacing the previous v3.4.2. This is a minor technical update and does not affect the study content or data.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-status notice and Revision: v3.4.1.SummaryDifference0.2%

- Check86 days agoChange DetectedAdded a government funding notice about potential delays and updated the site to version v3.4.1; removed version v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.